Last week in Boston, I joined a small dinner with some of the most forward‑thinking minds in drug R&D, manufacturing, and QC — scientists, informatics leaders, and data owners from global life sciences firms. At the dinner and over two days at the adjacent Lab of the Future conference, one question kept surfacing:
What is the scientist’s role in the lab of the future — and what does that demand from the platforms we build?
It sounds abstract. From where I sat, it’s one of the most practical questions in front of Scientific IT and science leadership — and the answer should be reshaping how we design every tool, platform, and workflow that touches scientific data.
The Scientist Today: Overloaded, Not Obsolete
Scientists are still the center of gravity in drug discovery and development. They design experiments, interpret results, and make critical calls on whether a target, batch, or assay is worth pursuing. Those decisions still rely on domain expertise, context, and accountability — not on an LLM prompt.
But the scientists I met at Lab of the Future are stretched in ways that weren’t true even five years ago. Their world is an ever‑expanding stack: instruments, LIMS, ELNs, LES, CDS, MES, data lakes, dashboards, and now AI tools — many of which don’t interoperate particularly well. They spend time searching for and moving data, fixing context, and reconciling systems instead of thinking about data and making decisions.
There is also a very real tension around AI itself. Many scientists — especially those with deep domain experience in R&D, CMC, and QC — remain skeptical of AI, not because they’re opposed to progress, but because they understand the stakes. They want to stay in the loop, and they want tools that are transparent, traceable, and explainable, not black boxes. That skepticism isn’t a marketing problem; it’s a signal that trust has to be earned, incrementally, through the design of the platforms IT puts in front of them.
One speaker put it bluntly: most AI investment so far has focused on better search and analysis. What’s missing is the operational layer — capacity visibility, cycle‑time risk, throughput constraints, and bottlenecks across DMTA or QC workflows. That’s the data that tells you whether the work will get done, not just what the work produced. A significant share of the cost and time in bringing a drug to market comes down to making the process understandable, scalable, and resilient — and then adjusting it as reality changes quarter by quarter. For Scientific IT, the mandate is clear: enable teams to get real work done in a dynamic environment, not just produce smarter dashboards.
From Experimenter to Bilingual Governor
Despite the anxiety around AI, the dominant theme was not “scientists will be replaced,” but “scientists are evolving.” Their role isn’t disappearing. It’s expanding — and quickly.
The idea of the “bilingual scientist” came up repeatedly. The scientist of the near future combines deep domain expertise with data fluency, AI literacy, critical thinking, and cross‑functional collaboration. They aren’t expected to become ML engineers, but they are expected to understand how models reach their conclusions — the determinism, the reasoning, the traceability — so they can evaluate outputs instead of treating AI as an oracle.
You can already see this shift in education. Programs are blurring the lines between “wet lab” and “dry lab,” blending scientific techniques with computational biology and data science. The new generation of scientists is comfortable writing Python, querying data, and working with models alongside designing and executing experiments.
One analogy that stuck with me was self‑driving cars. We’ve moved from driver‑assistance to more automated driving, but we still require a licensed human who can intervene, set constraints, and own responsibility. Labs are on a similar path: from AI‑assisted, to AI‑augmented, to eventually AI‑supervised workflows. In that future, the scientist looks less like a passenger and more like a governor of autonomous systems.
Human skills don’t go away in that model. They become more important: knowing which questions are worth asking, catching when an output doesn’t smell right, owning traceability across complex, regulated workflows, and making the final call when the stakes are high. This “bilingual governor” is a close cousin of what we at TetraScience call the Sciborg — people who bridge science, data, and business outcomes, and who can operate confidently at the boundary of autonomous and human‑driven work.
For Scientific IT, this evolving role is the primary user requirement. Any credible data and AI platform strategy now has to assume this bilingual scientist and governor as the default persona.
What This Means for Platforms
If the scientist is evolving this quickly, platforms cannot stay static. Tools that sit on top of siloed data, generic interfaces, and opaque models will become an anchor, not an accelerator.
Across conversations in Boston, three related themes surfaced over and over. First, governance and standardization: organizations know they need centralized data models, controlled ontologies, and reference data, but struggle to capture data in a way that remains usable across instruments, systems, teams, and time. Second, data readiness: “data first” has been a slogan for a decade, yet turning that into clean, connected, harmonized, vendor‑agnostic, AI‑ready scientific data is still a major lift. Third, change management and trust: technology often outruns culture, and scientists are asked to adopt new tools on top of existing workloads.
Underneath all three is a single theme: trust. Moving too fast, without a deliberate human‑AI partnership, doesn’t accelerate science. It undermines it — and it undermines the credibility of Scientific IT.
The flip side is also true. When you combine a governed, AI‑ready scientific data layer with experiences designed around real jobs‑to‑be‑done, you start to see structural impact.
The clearest ROI signal from the conference was the compression of DMTA cycles. One CRO outlined a four‑part AI strategy — LLM‑based report generation, AI‑assisted DMTA for cytotoxicity interpretation, AI for biomarker profiling across omics, cell painting, and behavioral data, and synthetic control arms to reduce animal use — all aimed at moving from program start to candidate in 18 months. A top‑20 pharma described a control tower, a decision‑room where data, models, and experimental results converge for portfolio decisions, delivering a 10% reduction in DMTA cycle times, 10% faster model training and fine‑tuning, and a 2x productivity lift for certain teams.
Across these examples, the pattern was consistent: scientists don’t need more data. They need to find the right data faster, understand it in context, and have tools — including AI — to act on it confidently.
A Platform Built for the Scientist of Today and Tomorrow
The lab of the future is not a single destination. It’s a continuous evolution — from AI‑assisted to AI‑augmented to AI‑supervised — driven by scientists whose roles are evolving just as quickly.
This is why we are introducing a new paradigm to our Scientific Data Foundry and the Tetra Data Platform. Not for the scientist of five years ago, and not for a hypothetical future persona, but for the scientists and scientific leaders working right now in your R&D, CMC, and QC organizations.
Our goal is not to automate scientists out of the equation. It’s to amplify what only they can do: exercise judgment on the questions that matter most, recognize when an output doesn’t fit the science, and turn data into discovery, robust processes, and safe, high‑quality products.
We’re building a platform that meets scientists and Scientific IT where they are, adapts to the job they’re doing, surfaces the right information at the right time, and earns trust through transparency, traceability, and performance.
The scientists of the future are already in your labs. The question is whether your platform is ready for them.
If you’re grappling with the same questions about scientists’ evolving roles, data readiness, and building trust in AI across R&D, CMC, and QC, my team and I would be happy to compare notes — and share how we’re rethinking the Tetra Data Platform around the scientist of today and tomorrow. Drop us a line.